Journalartikel

Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site


AutorenlisteLehmann, Petra; Salzberger, Bernd; Haerle, Peter; Aksentijevich, Ivona; Kastner, Daniel; Schoelmerich, Juergen; Rosenfeld, Stephanie; Mueller-Ladner, Ulf

Jahr der Veröffentlichung2010

Seiten311-315

ZeitschriftModern Rheumatology

Bandnummer20

Heftnummer3

ISSN1439-7595

eISSN1439-7609

Open Access StatusGreen

DOI Linkhttps://doi.org/10.1007/s10165-010-0273-y

VerlagOxford University Press


Abstract
We report on a 33-year-old female patient with a relatively mild clinical case of TNF-receptor associated periodic syndrome (TRAPS) and her 58-year-old father in whom end-stage renal disease due to TRAPS-related AA-amyloidosis has already developed. TRAPS was caused by a I170N mutation that has previously not been associated with amyloidosis. It remains unclear if an only mildly affected patient such as ours would benefit from treatment considering her father's severe course of disease. The relevant literature on this problem is reviewed.



Zitierstile

Harvard-ZitierstilLehmann, P., Salzberger, B., Haerle, P., Aksentijevich, I., Kastner, D., Schoelmerich, J., et al. (2010) Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site, Modern Rheumatology, 20(3), pp. 311-315. https://doi.org/10.1007/s10165-010-0273-y

APA-ZitierstilLehmann, P., Salzberger, B., Haerle, P., Aksentijevich, I., Kastner, D., Schoelmerich, J., Rosenfeld, S., & Mueller-Ladner, U. (2010). Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site. Modern Rheumatology. 20(3), 311-315. https://doi.org/10.1007/s10165-010-0273-y



Schlagwörter


AmyloidosisEPISODESEtanerceptETANERCEPTHereditary fever syndromeMONOCYTIC FASCIITISRENAL AMYLOIDOSISSYNDROME TRAPSTNFRSF1ATumor necrosis factor-receptor associated periodic syndrome


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 09:54